GlobeNewswire
-
Nordic Naturals Champions Ocean Conservation at 42nd Annual California Coastal Cleanup
23/09/2026 -
CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
23/09/2026 -
CROSSJECT et la BARDA consolident le plan de développement pédiatrique de ZEPIZURE® selon les attentes de la FDA avec un financement renforcé jusqu’en 2030
23/09/2026 -
Clareo Plastic Surgery Recognized as Best Plastic Surgeon in Boston
23/09/2026 -
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026 -
TwitchView® Quantitative Neuromuscular Monitoring Now Standardized Across Two Additional Midwest Academic Health Systems
23/09/2026 -
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
23/09/2026 -
New model-based analysis further supports the potential of TECVAYLI®▼ (teclistamab) plus daratumumab to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
23/09/2026 -
NexLife Includes a Licensed Doctor, a Nutrition Plan and Health Check-Ins After Treatment Starts in Every Compounded GLP-1 Subscription
23/09/2026 -
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
23/09/2026 -
BioAro Launches AI-Assisted LONgevity+™ Bioactives in the U.S. and U.K.
23/09/2026 -
SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma
23/09/2026 -
Altimmune to Participate in Stifel Cardiometabolic Forum
23/09/2026 -
Adaptyx Biosciences Granted FDA Breakthrough Device Designation For Its Continuous Cortisol Monitoring Technology and Is Accepted into FDA’s Total Product Life Cycle Advisory Program
23/09/2026 -
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease
23/09/2026 -
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
23/09/2026 -
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
23/09/2026 -
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
23/09/2026 -
Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations
23/09/2026
Pages